Abstract
Chronic thiamine deprivation in the rat leads to selective neuropathological damage in brainstem structures whereas treatment with the central thiamine antagonist, pyrithiamine, results in more widespread damage. In order to further elucidate the neurochemical mechanisms responsible for this selective damage, the thiamine-dependent enzyme complex pyruvate dehydrogenase (PDHC) was measured in 10 brain structures in the rat during progression of thiamine deficiency produced by chronic deprivation or by pyrithiamine treatment. Feeding of a thiamine-deficient diet to adult rats resulted in 5–7 weeks in ataxia and loss of righting reflex accompanied by decreased blood transketolase activities. PDHC activities were selectively decreased by 15–30% in midbrain and pons (lateral vestibular nucleus). Thiamine treatment of symptomatic rats led to reversal of neurological signs and to concomitant reductions of the cerebral PDHC abnormalities. Daily pyrithiamine treatment led within 3 weeks to loss of righting reflex and convulsions and to decreased blood transketolase of a comparable magnitude to that observed in chronic thiamine-deprived rats. No significant regional alterations of PDHC, however, were observed in pyrithiamine-treated rats.
Similar content being viewed by others
References
Peters, R. A. 1936. The biochemical lesion in vitamin B1 deficiency. Application of modern biochemical analysis in its diagnosis. Lancet 1:1161–1164.
Gaitonde, M. K., Fayein, N. A., andJohnson, A. L. 1975. Decreased metabolism in vivo of glucose into amino acids of the brain of thiamine-deficient rats after treatment with pyrithiamine. J. Neurochem. 24:1215–1223.
Butterworth, R. F. 1982. Neurotransmitter function in thiamine-deficiency encephalopathy. Neurochem. Int. 4:449–464.
Vorhees, C. V., Schmidt, D. E., andBarrett, R. J. 1978. Effects of pyrithiamin and oxythiamin on acetylcholine levels and utilization in rat brain. Brain Res. Bull. 3:493–496.
Butterworth, R. F., Hamel, E., Landreville, F., andBarbeau, A. 1979. Amino acid changes in thiamine-deficiency encephalopathy: some implications for the pathogenesis of Friedreich's Ataxia. Can. J. Neurol. Sci. 6:217–222.
Jolicoeur, F. B., Rondeau, D. B., Hamel, E., Butterworth, R. F., ANDBarbeau, A. 1979. Measurement of ataxia and related neurological signs in the laboratory rat. Can. J. Neurol. Sci. 6:209–216.
Glowinski, J., andIversen, L. L. 1966. Regional studies of catecholamines in the rat brain. J. Neurochem. 13:655–669.
Paxinos, G., andWatson, C. 1982. The rat brain in stereotaxic coordinates. Academic Press, New York.
Massod, M. F., McGuire, S. L., andWerner, K. R. 1971. Analysis of blood transketolase activity. Amer. J. Clin. Path. 55:465–470.
Ksiezak-Reding, H., Blass, J. P., andGibson, G. E. 1982. Studies on the pyruvate dehydrogenase complex in brain with the arylamine acetyltransferase-coupled assay. J. Neurochem. 38:1627–1636.
Butterworth, R. F., andGiguère, J. F. 1984. Pyruvate dehydrogenase activity in regions of the rat brain during postnatal development. J. Neurochem. 43:280–282.
Sheu, K. F. R., Lai, J. C. K., andBlass, J. P. 1983. Pyruvate dehydrogenase phosphate (PDHb) phosphatase in brain: activity, properties and subcellular localization. J. Neurochem. 40:1366–1372.
Jope, R., andBlass, J. P. 1976. The regulation of pyruvate dehydrogenase in brain in vivo. J. Neurochem. 26:709–714.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., andRandall, R. J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265–275.
Dreyfus, P. M. 1962. Clinical application of blood transketolase determinations. New Engl. J. Med. 267:596–598.
Warnock, L. G., Prudhomme, C. R., andWagner, C. 1978. The determination of thiamin pyrophosphate in blood and other tissues, and its correlation with erythrocyte transketolase activity. J. Nutr. 108:421–427.
Waldenlind, L., Borg, S., andVikander, B. 1981. Effect of peroral thiamine treatment on thiamine contents and transketolase activity of red blood cells in alcoholic patients. Acta Med. Scand. 209:209–212.
McCandless, D. W., andSchenker, S. 1968. Encephalopathy of thiamine deficiency: studies of intracerebral mechanisms. J. Clin. Invest. 47:2268–2280.
Collins, G. H. 1967. Glial cell changes in the brain stem of thiamine-deficient rats. Am. J. Pathol. 50:791–803.
Robertson, D. M., Wasan, S. M., andSkinner, D. B. 1968. Ultrastructural features of early brain stem lesions of thiamine-deficient rats. Am. J. Pathol. 52:1081–1087.
Tellez, I., andTerry, R. D. 1968. Fine structure of the early changes in the vestibular nuclei of the thiamine-deficient rat. Am. J. Pathol. 52:777–794.
Pincus, J. H., andGrove, I. 1970. Distribution of thiamine phosphate esters in normal and thiamine-deficient brain. Exp. Neurol. 28:477–483.
Murdock, D. S., andGubler, C. J. 1973. Effects of thiamine deficiency and treatment with the antagonists, oxythiamine and pyrithiamine, on the levels and distribution of thiamine derivatives in rat brain. J. Nutr. Sci. Vitaminol. 19:237–249.
Dreyfus, P. M., andHauser, G. 1965. The effect of thiamine deficiency on the pyruvate decarboxylase system of the central nervous system. Biochim. Biophys. Acta 104:78–84.
Pincus, J. H., andWells, K. 1972. Regional distribution of thiamine-dependent enzymes in normal and thiamine-deficient brain. Exp. Neurol. 37:495–501.
Heinrich, C. P., Stadler, H., andWeiser, H. 1973. The effect of thiamine deficiency on the acetylcoenzyme A and acetylcholine levels in the rat brain. J. Neurochem. 21:1273–1281.
Gubler, C. J. 1968. Enzyme studies in thiamine deficiency. Int. J. Vitamin Res. 38:287–303.
Jones, J. H., andDe Angeli, E. 1960. Thiamine deficiency and the in vivo oxidation of lactate and pyruvate labeled with14C. J. Nutr. 70:537–546.
Gubler, C. J. 1961. Studies on the physiological functions of thiamine. J. Biol. Chem. 236:3112–3120.
Koeppe, R. E., O'Neal, R. M., andHahn, C. H. 1954. Pyruvate decarboxylation in thiamine deficient brain. J. Neurochem. 11:695–699.
Inoue, A., Shim, S., andIwata, H. 1970. The activation of thiamine diphosphatase by ATP in rat brain. J. Neurochem. 17:1373–1382.
McCandless, D. S., andSchwartzenburg, F. C. Jr. 1981. The effect of thiamine deficiency on energy metabolism in cells of the lateral vestibular nucleus. Res. Comm. Psych. Psychiat. Behav. 6:183–190.
Vorhees, C. V., Schmidt, D. E., Barrett, R. J., andSchenker, S. 1977. Effects of thiamin deficiency on acetylcholine levels and utilization in vivo in rat brain. J. Nutr. 107:1902–1908.
Troncoso, J. C., Johnston, M. V., Hess, K. M., Griffin, J. W., andPrice, D. L. 1981. Model of Wernicke's Encephalopathy. Arch. Neurol. 38:350–354.
Aikawa, H., Watanabe, I. S., Furuse, T., Iwasaki, Y., Satoyoshi, E., Sumi, T., andMoroji, T. 1984. Low energy levels in thiamine-deficient encephalopathy. J. Neuropathol. Exp. Neurol. 43:276–287.
Rindi, G., andPerri, V. 1961. Uptake of pyrithiamine by tissue of rats. Biochem. J. 80:214–216.
Nose, Y., Iwashima, A., andNishino, H. 1974. Thiamine uptake by rat brain slices. Pages 157–168,in Gubler, C. J., Fujiwara, M., andDreyfus, P. M. (eds.), Thiamine, John Wiley, New York.
Cooper, J. R. 1968. The role of thiamine in nervous tissue: the mechanism of action of pyrithiamine. Biochim. Biophys. Acta 156:368–373.
Cooper, J. R., andPincus, J. H. 1979. The role of thiamine in nervous tissue. Neurochem. Res. 4:223–239.
Gibson, G. E., Ksiezak-Reding, H., Sheu, K. F. R., Mykytyn, V., andBlass, J. P. 1984. Correlation of enzymatic, metabolic and behavioral defects in thiamin deficiency and its reversal. Neurochem. Res. 9:803–814.
Bennett, C. D., Jones, J. H., andNelson, J. 1986. The effects of thiamine deficiency on the metabolism of the brain. J. Neurochem. 13:449–459.
Butterworth, R. F., Giguère, J. F., andBesnard, A. M. 1985. Region-selective changes of α-ketoacid dehydrogenases in experimental thiamine-deficiency encephalopathy. (Abstr) J. Neurochem.44(Suppl), S170B.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Butterworth, R.F., Giguere, JF. & Besnard, AM. Activities of thiamine-dependent enzymes in two experimental models of thiamine-deficiency encephalopathy:. Neurochem Res 10, 1417–1428 (1985). https://doi.org/10.1007/BF00964982
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00964982